Zafirlukast
NDC 42291-971, zafirlukast, tablet, coated, from AvKARE.
- Product NDC
- 42291-971
- Status
- Listed
- Labeler
- AvKARE
- Dosage form
- TABLET, COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA020547
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/42291-971 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ZAFIRLUKAST20 mg/1
Pharmacologic classes
Cytochrome P450 2C9 Inhibitors [MoA]; Leukotriene Receptor Antagonist [EPC]; Leukotriene Receptor Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 42291-971-60 | 42291097160 | 60 TABLET, COATED in 1 BOTTLE (42291-971-60) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/f89a821d-396f-a3aa-e053-6294a90a4577
Use it
Look up 42291-971 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/42291-971 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 42291-971. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.